Skip to Main Content

The number of complaints filed in the U.K. against drug makers over marketing infractions jumped substantially last year, according to the latest figures compiled by an industry-sponsored watchdog.

Overall, 76 complaints were registered in 2016, a 40 percent rise from the 54 that were filed in the previous year and, notably, there was a 30 percent jump in the most serious type of complaint — violations that discredit the entire industry. Many of the largest drug makers made this list. In addition, the number of individual allegations contained in each complaint reviewed was 420 last year, up from 198 in 2015.


Last year, was a “very busy year,” said William Harbage, who chairs the appeals board at the Prescription Medicines Code of Practice Authority, in the new report. The PMCPA was created in 1993 by the U.K. pharmaceutical industry trade group in hopes of bolstering confidence in drug makers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.